Talphera, Inc.
Talphera, Inc. (TLPH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tlph · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Talphera, Inc. (TLPH) measures how much investors pay for each dollar of the company's trailing earnings. TLPH's current PE ratio of N/A is calculated by dividing its stock price of $0.85 by its TTM earnings per share of -$0.34.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Talphera, Inc.You TLPH | $17M | N/A | — | -$0.34 |
 Apimeds Pharmaceuticals US, Inc APUS | $2M | N/A | — | -$0.55 |
 Cosmos Health Inc. COSM | $14M | N/A | — | -$0.63 |
 iBio, Inc. IBIO | $27M | N/A | — | -$1.75 |
 Intensity Therapeutics, Inc. INTS | $7M | N/A | — | -$0.86 |
 Iterum Therapeutics plc ITRM | $2M | N/A | — | -$1.26 |
 MIRA Pharmaceuticals, Inc. MIRA | $42M | N/A | — | -$0.44 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.34 | — | |
2024-12-31 FY2024 | — | $-0.50 | — | |
2023-12-31 FY2023 | — | $-1.29 | — | |
2022-12-31 FY2022 | 0.39x | $5.74 | — | |
2021-12-31 FY2021 | — | $-5.86 | — | |
2020-12-31 FY2020 | — | $-9.47 | — | |
2019-12-31 FY2019 | — | $-13.45 | — | |
2018-12-31 FY2018 | — | $-16.14 | — | |
2017-12-31 FY2017 | — | $-21.97 | — | |
2016-12-31 FY2016 | — | $-19.05 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Talphera, Inc. (TLPH) measures how much investors pay for each dollar of the company's trailing earnings. TLPH's current PE ratio of N/A is calculated by dividing its stock price of $0.85 by its TTM earnings per share of -$0.34.
Frequently asked questions
TLPH pe ratio · 6 questionsTLPH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.85 and TTM EPS of -$0.34. Data sourced from Financial Modeling Prep via TLPH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Talphera, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09